Home

Join us at the 24^th Annual Market Access Summit in fall 2025! This premier event brings together market access leaders, policy experts, and industry innovators from across the healthcare landscape. Register now to connect, learn, and shape the future of patient access in Canada.

• Navigate HTA and reimbursement frameworks across provinces.
• Craft effective stakeholder engagement
• Harness real-world evidence to drive access and funding decisions.
• Leverage data and analytics to inform market access planning.
• Align policy, pricing, and innovation to ensure sustainable access for patients.

This summit features notable organizations, including Canada’s Drug Agency (CDA-AMC), Gilead Sciences, Sandoz Canada, the PMPRB, AbbVie, the pCPA, and many more!

Enhance access to pharmaceuticals and MedTech with patient-focused strategies. Delve into all the hottest topics discussed over two incredible days.

• Hear the latest government guidance directly from the President and CEO of Canada’s Drug Agency (CDA-AMC).
• Learn innovative approaches to reimbursement for both private and public payers with insights from the pCPA and the PMPRB.
• Better understand how pathways to market access can be optimized with insights from Bayer, Cystic Fibrosis Canada, and others.
• Define what value means to different stakeholders with experts from AbbVie and Eisai Canada.
• Navigate the challenges and opportunities of international market access with leaders from Gilead Sciences and Sandoz.

Whether you’re focused on reimbursement, pricing strategy, patient experience or real-world evidence, this summit delivers the insights and connections you need to drive meaningful access for patients across Canada.

WHO WILL BENEFIT FROM THE EVENT?

Senior Executives From:

• Pharmaceuticals: Market Access, Government Affairs, Health Technology Assessment (HTA) and Reimbursement, Real-World Evidence, Pharma Economics, Pricing, Patient Access Programs, Medical Affairs
• BioTech: Market Access, Government Affairs, HTA and Reimbursement, Real-World Evidence, Pharma Economics, Pricing, Patient Access Programs, Medical Affairs
• MedTech: Market Access & Reimbursement, Health Economics and Outcomes Research (HEOR), Value-Based Partnerships, Strategic Policy
• Provincial: Drug Programs, Health System Planning, Reimbursement and Coverage, Policy, Public Drug Plans, Health Innovation Strategy, Health Technology Assessment (HTA)
• Federal: Market Access, Policy, Health Economists, Senior Policy Analysts, Regulatory Affairs, HTA, Pharmaceutical Policy and Pricing
• Private Payers: Group Benefits, Drug Benefit Solutions, Pharmacy Services, Health Benefits Strategy
• Patient Groups: Senior Management, Patient Advocacy, Access and Equity
• Healthcare: Patient Experience, Patient Relations, Patient-Centred Care Teams
• Educational Institutions: Health Policy Researchers, Health Systems Programs